Search Results - "Zahaf, K."

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies by Ilie, M., Long-Mira, E., Bence, C., Butori, C., Lassalle, S., Bouhlel, L., Fazzalari, L., Zahaf, K., Lalvée, S., Washetine, K., Mouroux, J., Vénissac, N., Poudenx, M., Otto, J., Sabourin, J.C., Marquette, C.H., Hofman, V., Hofman, P.

“…High expression of programmed death ligand-1 (PD-L1) on tumor cells (TC) and/or on tumor-infiltrating immune cells (IC) is associated with a high response rate…”
Get full text

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma by Ilie, M., Long, E., Butori, C., Hofman, V., Coelle, C., Mauro, V., Zahaf, K., Marquette, C.H., Mouroux, J., Paterlini-Bréchot, P., Hofman, P.

“…A subgroup of anaplastic lymphoma kinase (ALK)-rearranged lung tumours can respond to ALK inhibitors. Until now, the ALK status in circulating tumour cells…”
Get full text

Association of combined PD‐L1 expression and tumour‐infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma by Bence, C., Hofman, V., Chamorey, E., Long‐Mira, E., Lassalle, S., Albertini, A.F., Liolios, I., Zahaf, K., Picard, A., Montaudié, H., Lacour, J.P., Passeron, T., Andea, A.A., Ilie, M., Hofman, P.

“…Background Recent advances obtained with immune checkpoint inhibitors (ICIs) targeting the programmed cell death‐1 (PD‐1) protein have significantly improved…”
Get full text

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 by De Donatis, G M, Le Pape, E, Pierron, A, Cheli, Y, Hofman, V, Hofman, P, Allegra, M, Zahaf, K, Bahadoran, P, Rocchi, S, Bertolotto, C, Ballotti, R, Passeron, T

Get full text

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 by De Donatis, G M, Pape, E L, Pierron, A, Cheli, Y, Hofman, V, Hofman, P, Allegra, M, Zahaf, K, Bahadoran, P, Rocchi, S, Bertolotto, C, Ballotti, R, Passeron, T

“…Enhancer of Zeste homologue 2 (EZH2) belongs to the polycomb repressive complex 2 and catalyzes the methylation of histone H3 lysine 27. These pivotal…”
Get full text

Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma by Falk, A.T., Yazbeck, N., Thon, L., Guibert, N., Hofman, V., Zahaf, K., Lespinet, V., Bordone, O., Tanga, V., Washetine, K., Cohen, C., Venissac, N., Mouroux, J., Marquette, C.-H., Brest, P., Ilié, M., Hofman, P.

Get full text

Erratum: NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 by De Donatis, G M, Le Pape, E, Pierron, A, Cheli, Y, Hofman, V, Hofman, P, Allegra, M, Zahaf, K, Bahadoran, P, Rocchi, S, Bertolotto, C, Ballotti, R, Passeron, T

“…Correction to: Oncogene advance online publication 14 September 2015; doi:10.1038/onc.2015.331 Following the online publication of this article the authors…”
Get full text

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial by Wheeler, Cosette M, Dr, Prof, Castellsagué, Xavier, PhD, Garland, Suzanne M, Prof, Szarewski, Anne, PhD, Paavonen, Jorma, Prof, Naud, Paulo, Prof, Salmerón, Jorge, Prof, Chow, Song-Nan, Prof, Apter, Dan, MD, Kitchener, Henry, Prof, Teixeira, Júlio C, MD, Skinner, S Rachel, PhD, Jaisamrarn, Unnop, Prof, Limson, Genara, Prof, Romanowski, Barbara, Prof, Aoki, Fred Y, Prof, Schwarz, Tino F, Prof, Poppe, Willy A J, Prof, Bosch, F Xavier, PhD, Harper, Diane M, MD, Huh, Warner, MD, Hardt, Karin, PhD, Zahaf, Toufik, PhD, Descamps, Dominique, MD, Struyf, Frank, MD, Dubin, Gary, MD, Lehtinen, Matti, Prof

“…Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the…”
Get full text

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma by Ilie, M, Long, E, Butori, C, Hofman, V, Coelle, C, Mauro, V, Zahaf, K, Marquette, C H, Mouroux, J, Paterlini-Bréchot, P, Hofman, P

“…A subgroup of anaplastic lymphoma kinase (ALK)-rearranged lung tumours can respond to ALK inhibitors. Until now, the ALK status in circulating tumour cells…”
Get full text